RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib Society November 19, 2020 RedHill Biopharma Ltd (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced that the U.S. Phase 2 study with opaganib (Yeliva®,…
